Kamini Raghuram | Drug Safety and Risk Management | Best Researcher Award

Dr. Kamini Raghuram | Drug Safety and Risk Management | Best Researcher Award

Staff Neonatologist and Developmental Pediatrician at University of Toronto | Canada

Dr. Kamini Raghuram is a clinician-scientist specializing in developmental and behavioral pediatrics, neonatal-perinatal medicine, and clinical epidemiology. With a strong foundation in pediatrics, she has combined clinical expertise with cutting-edge research to advance outcomes in high-risk and preterm infants. Her work bridges clinical practice, epidemiology, and innovative technological tools such as automated video-based analysis for motor impairment. Dr. Raghuram has been a principal and co-investigator on numerous funded projects and has published extensively in leading pediatric and neonatal journals. She is widely recognized for her dedication to improving long-term neurodevelopmental outcomes in vulnerable infant populations.

Publication Profile 

Orcid

Education 

Dr. Kamini Raghuram completed her Doctor of Medicine (MD) at the University of Toronto, followed by FRCPC training in General Pediatrics, Neonatal and Perinatal Medicine, and Developmental and Behavioral Pediatrics at the same institution. She earned a Master of Science in Clinical Epidemiology and Health Care Research from the Institute of Health Policy, Management, and Evaluation, University of Toronto, where her thesis focused on video-based motor impairment analysis in preterm infants. Earlier, she obtained a Bachelor of Applied Science in Chemical and Biological Engineering from the University of British Columbia, graduating as class valedictorian and recognized for outstanding research proficiency.

Experience 

Dr. Kamini Raghuram has held extensive clinical and academic positions across pediatrics, neonatology, and developmental medicine. She has served as a clinician-investigator, integrating patient care with translational research to develop evidence-based approaches for preterm infants. Her work includes leading clinical trials, advancing quality improvement initiatives, and applying machine learning and automated video analysis for early detection of motor and neurodevelopmental impairments. With expertise spanning neonatal intensive care, developmental follow-up, and health outcomes research, she has collaborated nationally and internationally to improve clinical pathways for high-risk infants. Her experience reflects a unique combination of bedside practice and pioneering research in pediatrics.

Awards and Honors 

Dr. Kamini Raghuram has received numerous awards and funding recognitions for her research and clinical excellence. These include CIHR grants exceeding $2 million, innovation fund competitions, and recognition for her work on neonatal outcomes. She has won presentation and research awards at the University of Toronto, The Hospital for Sick Children, and international conferences. Honors such as the Excellence in Academic Coaching Award, Quality Improvement Award, Canada Graduate Scholarship, and early-career fellowships highlight her leadership and academic impact. Earlier, as an engineering student, she received the Lefevre Gold Medal and delivered the valedictorian address at the University of British Columbia.

Research Focus 

Dr. Kamini Raghuram research focuses on improving neurodevelopmental and health outcomes in preterm and high-risk infants through early detection, intervention, and long-term follow-up strategies. She applies advanced tools, including automated video analysis, MRI biomarkers, and large-scale database studies, to identify predictors of motor and cognitive impairment. Her work integrates clinical epidemiology with neonatal and developmental pediatrics, emphasizing translational approaches from bench to bedside. She is also involved in clinical trials addressing interventions such as coadministration therapies and surgical decision-making in fetal medicine. Her ultimate goal is to enhance early diagnosis, optimize interventions, and improve quality of life for vulnerable children.

Publication Top Notes

Caregiver Experiences, Healthcare Provider Perspectives and Child Outcomes with Virtual Care in a Neonatal Neurodevelopmental Follow-Up Clinic: A Mixed-Methods Study

Automated Movement Analysis to Predict Cerebral Palsy in Very Preterm Infants: An Ambispective Cohort Study

Conclusion

Dr. Kamini Raghuram is a highly deserving candidate for the Best Researcher Award. Her career reflects a rare combination of clinical excellence, research innovation, and dedication to improving outcomes for preterm infants. With substantial grant funding, groundbreaking studies in automated movement analysis, and leadership in advancing neonatal care, she exemplifies the qualities of a leading researcher. While opportunities exist to expand her global influence and further scale her innovations, her proven track record of impactful, patient-centered research makes her an outstanding nominee for this prestigious recognition.

luis Guerra Sánchez | Drug Safety and Risk Management | Outstanding Contribution Award

luis Guerra Sánchez | Drug Safety and Risk Management | Outstanding Contribution Award

Dr. luis Guerra Sánchez, HGU Gregorio Marañon, Spain

Dr. Luis Guerra Sánchez is an esteemed Spanish nurse and researcher with a Ph.D. in Nursing Care Research 🎓 from Universidad Complutense de Madrid. With degrees in Nursing (Graduate & Diploma) 🏥 and a Master’s in Nursing Research, his academic journey reflects excellence and dedication. He has completed over 40 advanced professional trainings 🧠, specializing in chronic care, diabetes, neonatal intensive care, statistics, leadership, and biomedical research 📊🧪. Dr. Sánchez is deeply committed to healthcare innovation, evidence-based practice, and continuous learning, making significant contributions to nursing education and clinical practice. A true advocate for patient-centered care and professional growth.

Publication Profile 

Orcid

Education

Dr. Luis Guerra Sánchez holds a robust academic foundation in nursing, highlighted by a Ph.D. in Investigación en Cuidados de Enfermería 🎓 and a Master’s degree in Investigación en Cuidados from Universidad Complutense de Madrid 🏛️. His commitment to lifelong learning is evident in his completion of over 40 specialized training programs, covering diverse areas such as chronic patient care, diabetes management, neonatal intensive care, biomedical research, statistics, and healthcare leadership 📊🧪💉. With extensive experience in clinical and academic settings, Dr. Sánchez continues to contribute meaningfully to healthcare excellence and nursing advancement across Spain and beyond.

Awards

Dr. Luis Guerra Sánchez has pursued extensive professional development through a wide array of training programs and certifications 🎓. His credentials include courses in research methodology 🧪, statistical analysis 📊, and healthcare management 🏥. He holds specialized certifications in critical care 🚑, cardiology ❤️, and neonatology 👶, reflecting his deep commitment to high-level clinical expertise. With over four decades of continuous learning, his qualifications span from advanced clinical practices to leadership and teaching in healthcare. These achievements underline his dedication to excellence and innovation in patient care, nursing education, and evidence-based medical practice.

Experience

Dr. Luis Guerra Sánchez brings a wealth of experience in both clinical practice and scientific research 🏥📚. His professional journey spans diverse healthcare settings, where he has contributed significantly through patient care, management, and academic mentoring 👨‍⚕️👨‍🏫. With numerous certifications and continuous training in specialized areas such as cardiology, neonatology, and chronic disease management ❤️👶, he exemplifies lifelong learning. His involvement in research projects and data-driven healthcare innovations reflects a strong dedication to evidence-based practice and improving patient outcomes 🔎📈. Dr. Sánchez’s impact extends across clinical, educational, and investigative domains, making him a leader in modern nursing.

Research Focus

Dr. Luis Guerra Sánchez’s scholarship sits at the crossroads of clinical nutrition, cardiovascular nursing, and patient‑safety science. His randomized trials explore how tailored dietary strategies can reverse malnutrition, boost functional capacity, and elevate quality of life in chronic heart‑failure patients 🫀📈. Parallel work standardises intravenous therapies and analgesia–sedation practices in ICUs, tightening medication‑safety protocols 💉🔒. Through multicentre audits, he spotlights delirium, restraint use, and nutritional risk—generating evidence for nurse‑led interventions that cut complications and hospital days 🏥⏱️. Overall, Luis champions evidence‑based, nurse‑driven care models that fuse nutrition science with cardiology and critical‑care best practices, improving outcomes across vulnerable populations .

Publication Top Notes

  • Effect of a double nutritional intervention on the nutritional status, functional capacity, and quality of life of patients with chronic heart failure: 12-month results from a randomized clinical trial
  • Standardization and Chemical Characterization of Intravenous Therapy in Adult Patients: A Step Further in Medication Safety.
  • Assessment of analgesia, sedation, physical restraint and delirium in patients admitted to Spanish intensive care units. Proyecto ASCyD
  • Nutritional intervention in patients with heart failure. 3 month results of a clinical trial
  • [Prevalence of undernutrition in hospital patients with unbalanced heart failure; subjective global assessment like prognosis sign].
  • [Nutritional screening in heart failure patients: 5 methods review].

Dhanpat Sharma | Drug Safety and Risk Management | Best Researcher Award

Dhanpat Sharma | Drug Safety and Risk Management | Best Researcher Award

Dr. Dhanpat Sharma, Central University of Haryana, India

Dr. Dhanpat Sharma is a passionate physicist who recently submitted his Ph.D. thesis at the Central University of Haryana, India, focusing on the generation of magnetic fields during heavy ion collisions. His work bridges theoretical simulations with experimental studies involving low-intensity magnetic fields for environmental applications. He has published extensively on photocatalysis, nanomaterials, and nuclear physics. Dr. Sharma is a recipient of multiple prestigious fellowships, including UGC-CSIR NET-JRF and GATE, and has actively presented his research at national and international conferences. His innovative insights continue to contribute significantly to nuclear and materials science.

Publication Profile

orcid

Education

Dr. Dhanpat Sharma 🎓 is a dedicated physicist currently pursuing his Ph.D. in Physics at the Central University of Haryana, Mahendergarh, India, from August 2019 to April 2025. His research, guided by Prof. Suneel Kumar, focuses on the study of nuclear flow, nuclear stopping, magnetic fields, and their inter-correlations in heavy ion collisions ⚛️. He earned his M.Sc. in Physics from Maharishi Dayanand University, Rohtak, between 2016 and 2018 📘. Prior to that, he completed his B.Sc. in Physics, Chemistry, and Mathematics at Kirori Mal College, University of Delhi 🎓, from 2012 to 2016, laying a strong foundation for his scientific journey.

Experience

Dr. Dhanpat Sharma 💻 has hands-on experience in coding within the Quantum Molecular Dynamics (QMD) and Isospin-dependent Quantum Molecular Dynamics (IQMD) frameworks, which are essential tools for simulating heavy ion collisions at intermediate energies ⚛️. His work involves implementing and modifying simulation codes to analyze nuclear flow, nuclear stopping, and magnetic field effects. Through this expertise, Dr. Sharma has gained a deep understanding of the computational modeling of complex nuclear interactions 🧠. His coding proficiency allows him to conduct high-level theoretical research, contributing significantly to the field of nuclear physics 🔬, and enhancing predictive accuracy in nuclear collision studies.

Awards

Dr. Dhanpat Sharma 🏅 has been recognized for his academic excellence with several prestigious awards and honors. He qualified the UGC-CSIR NET-JRF twice, in December 2018 and July 2019, earning a fellowship for his Ph.D. studies 🎓. Additionally, he cleared the GATE exam in February 2019, further showcasing his strong command in physics 📘. Dr. Sharma also qualified for the IGCAR entrance with an impressive All India Rank of 34 🔬. Demonstrating consistent academic merit, he secured the 4th rank in the Ph.D. entrance test conducted by the University of Delhi, solidifying his position among top research scholars in India 🇮🇳.

Research Focus

Dr. Dhanpat Sharma focuses on magneto-photocatalysis, heavy-ion collision physics, and advanced nanomaterials for energy and environmental applications. His research spans the development of photocatalytic materials like α-γ-Fe₂O₃/rGO for antibiotic degradation 💊, to synthesizing nanocomposites for energy storage ⚡ using waste-derived Fe₃O₄. In nuclear physics, he explores the evolution of magnetic and electromagnetic fields 🧲 during heavy-ion collisions, studying correlations with nuclear stopping and elliptical flow. His interdisciplinary expertise bridges materials science, nuclear theory, and applied nanotechnology 🧪, addressing both sustainable tech and fundamental particle interactions in extreme conditions.

Publication Top Notes

Magnetic field and dissolved oxygen assisted ultra-high photocatalytic activity of α-γ-Fe2O3 heterophase wrapped with rGO sheets for the removal of rifampicin

Waste toner derived Fe3O4 nanoparticles embedment into PANI matrix as an advanced electrode for supercapacitor

Probing the contribution of various mass fragments in the production of magnetic field during heavy ion collisions

Correlation between elliptical flow and nuclear stopping around the transition energy in mid rapidity zone

Influence of symmetry energy on electromagnetic field during heavy-ion collisions
Correlation between magnetic field and nuclear stopping in different rapidity segments during heavy ion collisions
Production of magnetic field due to heavy ion collisions around transition energy

Mrs .Elena Reshetova, Drug Safety and Risk Management,Best Researcher Award-1150

Mrs .Elena Reshetova,Drug Safety and Risk Management ,Best Researcher Award

 Mrs .Elena Reshetova, at Institute of Technical Chemistry UB RAS,Russia

Author Profile

 

🎓Education:

  • Ph.D. in Physical Chemistry, 2011, Perm State University
    Dissertation: «The regularities of retention and separation of profen enantiomers on chiral stationary phases»
  • M.Sc. in Chemistry, 2006, Perm State University

Research and Innovations:

Elena has led multiple research projects, including:
  1. Retention mechanisms of weak electrolytes in chiral chromatography (Russian Science Foundation, 2023-2024)
  2. Investigation of the adsorption of enantiomers of hydroxy acids and their derivatives on chiral stationary phases (RFBR, 2018-2020)
  3. The regularities of enantioselective adsorption of drugs on chiral stationary phases of different chemical nature (RFBR, 2015-2017)
  4. Adsorption of enantiomers of biologically active compounds on chiral stationary phases under high-performance liquid chromatography conditions (Grant of the President of RF, 2013-2014)
  5. Development of high performance liquid chromatography and capillary electrophoresis methods for resolution and analysis of bioactive substances enantiomers (RFBR, 2013-2014)
  6. The chromatographic separation of optic isomers under overloading column conditions (RFBR, 2010-2012)

Achievements and Recognitions:

  • Young Scientist Scholarship from the Russian Science Support Foundation (2009-2010)
  • Pavel Solov’ev Medal and Award from Perm Region Government (2014) for her work on isolating enantiomerically pure drug forms by chromatographic separation of optical isomers

Publications and Citations:

Elena has an extensive list of publications in high-impact journals, focusing on chromatographic enantioseparation and adsorption thermodynamics. Some notable publications include:

  1. Retention mechanisms of dipeptides on superficially porous particle vancomycin- and teicoplanin-based chiral stationary phases. Journal of Chromatography A, 2024.
  2. Chiral zwitterionic stationary phases based on Cinchona alkaloids and dipeptides: Application in chiral separation of dipeptides under reversed phase conditions. Journal of Chromatography A, 2024.
  3. Retention mechanisms of rasagiline and its analogues on superficially porous particle vancomycin- and teicoplanin-based chiral stationary phases. Journal of Chromatography A, 2023.

Areas of Research:

  • High-performance liquid chromatography on chiral stationary phases
  • Enantioseparations of chiral drugs and biologically active compounds
  • Development of analytical HPLC methods
  • Theory of adsorption and chromatographic analysis

Professional Memberships:

Elena is an active member of several professional organizations and collaborates on various grants, contributing significantly to the field of chemistry and material sciences.

Contributions to Science:
Elena’s research on the chromatographic behavior of new chiral stationary phases has advanced the understanding of enantiorecognition and retention mechanisms. Her theoretical models have provided valuable insights into the interaction of solvents and analytes, aiding the development of effective separation techniques for stereoisomers.

🎓Publication Top Noted:

Paper Title : Enantioselective chromatography of dipeptides on adsorbents with grafted antibiotics

  • Authors: Elena Reshetova
  • Journal: Conference abstract at Mendeleev Congress
  • Year: 2024
Paper Title : Chiral zwitterionic stationary phases based on Cinchona alkaloids and dipeptides: Application in chiral separation of dipeptides under reversed phase conditions
    • Authors: Leonid D. Asnin, Daria I. Ziganshina, Yana A. Klimova, Elena N. Reshetova, Jiří Tůma, Michal Kohout
    • Journal: Journal of Chromatography A
    • Year: 2024
Paper Title : Retention mechanisms of dipeptides on superficially porous particle vancomycin- and teicoplanin-based chiral stationary phases
  • Authors: Elena N. Reshetova, Anna S. Barashkova, Bulat F. Garifullin
  • Journal:Journal of Chromatography A
  • Year: 2024
Paper Title :Enantioselective chromatography of amines and dipeptides on superficially porous particle adsorbents with grafted teicoplanin and vancomycin antibiotics
  • Authors: Elena Reshetova
  • Journal:Conference abstract at All-Russian symposium with international participation “Physico-chemical problems of adsorption, structure and surface chemistry of nanoporous materials
  • Year: 2023

Paper Title :Retention mechanisms of rasagiline and its analogues on superficially porous particle vancomycin- and teicoplanin-based chiral stationary phases

  • Authors: Elena Reshetova, Leonid Asnin
  • Journal:Journal of Chromatography A
  • Year: 2023